RhumbLine Advisers
HSTO

RhumbLine Advisers’s Histogen Inc. Common Stock HSTO Stock Holding History

RhumbLine Advisers’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-114
Closed -$134K – 2946
2018
Q1 		$134K Buy
114
+1
+0.9% +$1.1K ﹤0.01% 2692
2017
Q4 		$104K Sell
113
-26
-19% -$24K ﹤0.01% 2770
2017
Q3 		$153K Buy
139
+3
+2% +$3.41K ﹤0.01% 2816
2017
Q2 		$156K Buy
+136
New +$166K ﹤0.01% 2828

Other funds holding HSTO

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
AIM
Alambic Investment Management Belvedere, California $9.12M AUM 34.54% 1-Year Est. Return
CM
Crestline Management Fort Worth, Texas $46.3M AUM 48.82% 1-Year Est. Return

RhumbLine Advisers's HSTO Position: Q2 2018 in Review

RhumbLine Advisers sold out of Histogen Inc. Common Stock (HSTO) in Q2 2018, closing a stake of 114 shares — an estimated $134K sold.

RhumbLine Advisers first reported a position in HSTO in Q2 2017 and held it in 4 quarters. The position peaked at $156K in Q2 2017. 61 funds tracked by Wall St. Rank hold HSTO as of Q2 2018.

  • RhumbLine Advisers reported no remaining Histogen Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • RhumbLine Advisers sold 114 Histogen Inc. Common Stock shares in Q2 2018, an estimated $134K.
  • RhumbLine Advisers first reported a position in Histogen Inc. Common Stock in Q2 2017 and held it in 4 quarters.
  • RhumbLine Advisers's Histogen Inc. Common Stock position peaked at $156K in Q2 2017.
  • 61 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q2 2018.

Based on RhumbLine Advisers's 13F filing for Q2 2018, filed 6 Aug 2018.